TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32274489

Group type: EXPERIMENTAL
Intervention: Verbal postoperative instructions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Written postoperative instructions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Verbal plus written postoperative instructions
Number of subjects: 150
Study: 33051255

Group type: COMPARATOR
Intervention: Low-dose SCS (initial dose ≤ 40 mg prednisone equivalent/d)
Number of subjects: 1375

Group type: COMPARATOR
Intervention: Medium-dose SCS (initial dose = 40-100 mg prednisone equivalent/d)
Number of subjects: 1375

Group type: COMPARATOR
Intervention: High-dose SCS (initial dose > 100 mg prednisone equivalent/d)
Number of subjects: 1375
Study: 32175588

Group type: EXPERIMENTAL
Intervention: Exposure to PM2.5
Number of subjects: 20874
Study: 34579127

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) combined with EPO and Iron Sulfate; 24 weeks/3 days per week at moderate intensity of full-body resistance exercises
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (CTL) without iron treatment (CTL-none); n = 19
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group treated only with iron sulfate or EPO (CTL-EPO or IRON); n = 19
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group treated with both iron sulfate and EPO (CTL-EPO + IRON); n = 76
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Resistance Training group without iron treatment (RT-none); n = 20
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Resistance Training group treated only with iron sulfate or EPO (RT-EPO or IRON); n = 18
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Resistance Training group treated with both iron sulfate and EPO (RT-EPO + IRON); n = 86
Number of subjects: 157
Study: 36154566

Group type: EXPERIMENTAL
Intervention: Enhanced prenatal care models with social support
Number of subjects: 77

Group type: COMPARATOR
Intervention: COVID-19-related stressors (childcare and tension at home)
Number of subjects: 77
Study: 34495078

Group type: EXPERIMENTAL
Intervention: Exercise training (ET) consisting of 3 weekly sessions of aerobic exercise, resistance exercises, and flexibility (72 sessions over 40±3.9 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (15 individuals)
Number of subjects: 44
Study: 32814123

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) machine for 2 × 15 min per session plus routine exercises for 1 h, three times a week for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Routine exercises for 1 h, three times a week for 4 weeks
Number of subjects: 21
Study: 36114553

Group type: EXPERIMENTAL
Intervention: Space creation with an orthodontic appliance, removal of the supernumerary tooth and application of direct orthodontic traction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Space creation with an orthodontic appliance, removal of the supernumerary tooth and monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 33618680

Group type: EXPERIMENTAL
Intervention: Simulator guided training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Tutor guided training
Number of subjects: 54
Study: 32100297

Group type: EXPERIMENTAL
Intervention: Teleconsultation (TC) follow-up
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hospital follow-up
Number of subjects: 110
Study: 35661801

Group type: EXPERIMENTAL
Intervention: 5-day time-restricted feeding
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial
Number of subjects: 8
Study: 33154086

Group type: EXPERIMENTAL
Intervention: Remote Directly Observed Therapy (R‐DOT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hailie Smartinhaler
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: INhaler Compliance Assessment device (INCA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Rafi‐tone App
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: NEMD (general)
Number of subjects: 35
Study: 34340097

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg rectal, administered twice within the same day, starting at twelve hours after triggering)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 214
Study: 33396257

Group type: EXPERIMENTAL
Intervention: Serve training after tennis training (ATS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Serve training before tennis training (BTS)
Number of subjects: 25
Study: 35961468

Group type: EXPERIMENTAL
Intervention: Sleep Hygiene and Education (SHE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT–I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBT–I + BLT combined and simultaneously delivered
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33347632

Group type: EXPERIMENTAL
Intervention: Anti-CGRP monoclonal antibodies
Number of subjects: 14
Study: 32988690

Group type: EXPERIMENTAL
Intervention: CoVER curriculum (four online modules and an in-person training guide)
Number of subjects: 1444

Group type: COMPARATOR
Intervention: Control (standard vaccine education)
Number of subjects: 1444

Group type: EXPERIMENTAL
Intervention: CoVER curriculum
Number of subjects: 1444
Study: 35157096

Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy with abdominal mesh attachment (TLH)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Vaginal hysterectomy with vaginal mesh attachment (TVH)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Both groups (TLH and TVH)
Number of subjects: 314
Study: 34154363

Group type: EXPERIMENTAL
Intervention: Probiotics supplementation combined with WeChat platform health management
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine follow‐up (Control group)
Number of subjects: 150
Study: 33068343

Group type: EXPERIMENTAL
Intervention: Combined treatment of abdominal moxibustion from 7 am to 9 am and rehabilitation training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with basic treatment of internal medicine and rehabilitation training
Number of subjects: 100
Study: 35281612

Group type: EXPERIMENTAL
Intervention: High-energy shockwave therapy (ESWT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Routine physical therapy (RPT)
Number of subjects: 42
Study: 32024497

Group type: EXPERIMENTAL
Intervention: Human infection studies (HIS)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Conditions for acceptability of HIS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Stakeholder perceptions
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ongoing assessment
Number of subjects: 26
Study: 36378691

Group type: EXPERIMENTAL
Intervention: Dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS)
Number of subjects: 3146

Group type: COMPARATOR
Intervention: Sirolimus-eluting Orsiro stent (O-SES)
Number of subjects: 3146
Study: 34326921

Group type: EXPERIMENTAL
Intervention: Xuefu Zhuyu granules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32517188

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acid (PUFA)‐rich breakfast
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acid (MUFA)‐rich breakfast
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saturated fatty acid (SFA)‐rich breakfast
Number of subjects: 60
Study: 36150356

Group type: EXPERIMENTAL
Intervention: PDMP alert for high dose
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PDMP alert for multiple prescriber episodes
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PDMP alerts
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Patient and medication characteristics (age, opioid dose, benzodiazepine use, co-morbidity)
Number of subjects: 241
Study: 33610904

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 478
Study: 32892222

Group type: EXPERIMENTAL
Intervention: Ibezapolstat
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 62
Study: 33273275

Group type: EXPERIMENTAL
Intervention: 9 weeks of multifaceted physiotherapy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Waiting-list controls
Number of subjects: 197
Study: 32415846

Group type: EXPERIMENTAL
Intervention: Sertraline (400 mg/day for 8 weeks, then tapered)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 21
Study: 32825982

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Resistance Training with Curcumin Supplement (RTC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Curcumin Supplement (C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 45
Study: 35564909

Group type: EXPERIMENTAL
Intervention: Sustainability Action Plan (SAP) for the SAGE intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) approach
Number of subjects: 0
Study: 34250690

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: EFIC procedures
Number of subjects: 63

Group type: COMPARATOR
Intervention: No EFIC procedures
Number of subjects: 63
Study: 34657779

Group type: EXPERIMENTAL
Intervention: Family‐Clinician Shared Decision‐Making (FCSDM) intervention
Number of subjects: 548

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 548
Study: 34509883

Group type: EXPERIMENTAL
Intervention: Rufinamide
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 35668423

Group type: EXPERIMENTAL
Intervention: SAIA-MH (multicomponent implementation strategy)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Attentional placebo control
Number of subjects: 16
Study: 35353055

Group type: EXPERIMENTAL
Intervention: TangPlan and WeChat
Number of subjects: 156
Study: 34127624

Group type: EXPERIMENTAL
Intervention: Lumbosacral orthosis (LSO) plus routine physical therapy for 3 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Routine physical therapy alone for 3 weeks
Number of subjects: 24
Study: 33032908

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg for 80 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 80 days
Number of subjects: 0
Study: 35998119

Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34272972

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control (no DA use)
Number of subjects: 382
Study: 33219117

Group type: EXPERIMENTAL
Intervention: Supervised exercise group (EG, n=146)
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Exercise prescription group (PG, n=144)
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Control group (CON, n=782)
Number of subjects: 1072
Study: 35277402

Group type: EXPERIMENTAL
Intervention: DLPFC-rTMS
Number of subjects: 50

Group type: COMPARATOR
Intervention: M1-rTMS
Number of subjects: 50
Study: 33896706

Group type: EXPERIMENTAL
Intervention: Smartphone-based cardiovascular risk reduction program using the 'BreastMate' application as an adjunct to standard care.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smartphone-based cardiovascular risk reduction program.
Number of subjects: 0
Study: 33144481

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 36417312

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 72

Group type: COMPARATOR
Intervention: Open colorectal surgery
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Recruitment strategies
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Use of surgical trainees
Number of subjects: 72
Study: 34324880

Group type: EXPERIMENTAL
Intervention: Enteral iron supplementation (mean 4.8 mg/kg/d in Epo group, 3.6 mg/kg/d in placebo group) at 60 days
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo (mean 3.6 mg/kg/d) at 60 days
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Epo (mean 4.8 mg/kg/d) at 60 days
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Iron dose at 90 days
Number of subjects: 692
Study: 32918513

Group type: EXPERIMENTAL
Intervention: Transcultural psychotherapy (TCP) - six sessions in addition to usual care
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 35691568

Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg empagliflozin
Number of subjects: 0
Study: 33298149

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins at 50 IU anti-Xa/kg twice daily or 75 IU anti-Xa twice daily in combination with aprotinin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins with aprotinin and anakinra (if hyperinflammation is present)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard thromboprophylaxis
Number of subjects: 0
Study: 33757380

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) treatment
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 98
Study: 35707984

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula Therapy (HFNC)
Number of subjects: 573

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure Therapy (CPAP)
Number of subjects: 573
Study: 33749321

Group type: EXPERIMENTAL
Intervention: OB-002H gel (5 vaginal daily doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched placebo (5 vaginal daily doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: OB-002H gel
Number of subjects: 30
Study: 32291608

Group type: EXPERIMENTAL
Intervention: Congrong Shujing Granules (CSGs) combined with Western medicine (WM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo combined with Western medicine (WM)
Number of subjects: 72
Study: 34964489

Group type: EXPERIMENTAL
Intervention: Automated algorithm for B-line detection and quantification
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Reviewer-adjusted count
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Manual count
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Automated algorithm
Number of subjects: 80
Study: 33899783

Group type: EXPERIMENTAL
Intervention: Couple-based intervention consisting of 3 advanced nurse-led, face-to-face sessions supported by web-based information
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Couple-based intervention
Number of subjects: 60
Study: 32986531

Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No Kinesiotaping (no-KT)
Number of subjects: 52
Study: 33318452

Group type: EXPERIMENTAL
Intervention: Training by novice trainers
Number of subjects: 24

Group type: COMPARATOR
Intervention: Training by experienced trainers
Number of subjects: 24
Study: 34436714

Group type: EXPERIMENTAL
Intervention: Contingency management intervention with cash incentives (up to $3650 per year)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33385757

Group type: EXPERIMENTAL
Intervention: Intensive Treatment (IT)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Standard Treatment (ST)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: No current alcohol use
Number of subjects: 303

Group type: COMPARATOR
Intervention: Problematic alcohol use
Number of subjects: 303

Group type: COMPARATOR
Intervention: Problematic use by study arm interaction
Number of subjects: 303
Study: 35348459

Group type: EXPERIMENTAL
Intervention: Fex-Can intervention (web-based, 12-week duration)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Fex-Can intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 124
Study: 34836821

Group type: EXPERIMENTAL
Intervention: Transparent face mask worn by health care professionals (n = 83)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard non-transparent face mask worn by health care professionals (n = 93)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Nurses (initial assessment)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Physicians (15 minutes later assessment)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Discrepancy in VAS scores between nurses and physicians
Number of subjects: 176
Study: 33501599

Group type: EXPERIMENTAL
Intervention: 3D whole heart volume (WHV) derived from non‐contrast cardiac computed tomography (CT)
Number of subjects: 3798

Group type: EXPERIMENTAL
Intervention: 3D whole heart volume (WHV)
Number of subjects: 3798
Study: 36216413

Group type: EXPERIMENTAL
Intervention: Augmented Reality Rehabilitation of Walking-Cerebral Palsy AVG
Number of subjects: 14

Group type: COMPARATOR
Intervention: Treadmill gait training (control)
Number of subjects: 14
Study: 33836723

Group type: EXPERIMENTAL
Intervention: Volunteer based information on waste segregation (I-MISS)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Existing routine waste segregation information (Control)
Number of subjects: 425
Study: 32515006

Group type: EXPERIMENTAL
Intervention: Volumetric laser endomicroscopy (VLE) full scans
Number of subjects: 29
Study: 33213527

Group type: EXPERIMENTAL
Intervention: Levamlodipine 5 mg (fasted)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amlodipine 10 mg (fasted)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Levamlodipine 5 mg (fed)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amlodipine 10 mg (fed)
Number of subjects: 48
Study: 36429677

Group type: EXPERIMENTAL
Intervention: Moderate-intensity plyometric exercise (MIPE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High-intensity plyometric exercise (HIPE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric exercise (LIPE)
Number of subjects: 37
Study: 34706311

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneous every 6 months) added to intensive urate-lowering therapy (ULT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intensive urate-lowering therapy (ULT) alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Denosumab/ULT
Number of subjects: 20

Group type: COMPARATOR
Intervention: ULT alone
Number of subjects: 20
Study: 32011496

Group type: EXPERIMENTAL
Intervention: Phellinus linteus (PL) 1000 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Phellinus linteus (PL) 2000 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 35512507

Group type: EXPERIMENTAL
Intervention: 12-week emotional support programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 32012346

Group type: EXPERIMENTAL
Intervention: Group A: prefabricated zirconia abutment with pressed ceramic
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group B: individualized CAD/CAM zirconia abutment with hand-layered technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 36501004

Group type: EXPERIMENTAL
Intervention: 392 mg/day of blackcurrant powder (low blackcurrant, BC, group, n = 16)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 784 mg/day of blackcurrant powder (high BC group, n = 11)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group, n = 13)
Number of subjects: 40
Study: 34185664

Group type: EXPERIMENTAL
Intervention: Mucoadhesive tablet containing pilocarpine, 5 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Mucoadhesive tablet without the active ingredient
Number of subjects: 25
Study: 35839010

Group type: EXPERIMENTAL
Intervention: Proximal femoral nail antirotation (PFNA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 87
Study: 32462276

Group type: EXPERIMENTAL
Intervention: Bovine sound dentin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Human dentin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: pH-cycling
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bovine dentin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flexural strength (MPa)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Compositional variables (i.e., PO4/amide I, CI, and %mineral)
Number of subjects: 120
Study: 36265171

Group type: EXPERIMENTAL
Intervention: Cervical dilators used concurrently with misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32597686

Group type: EXPERIMENTAL
Intervention: Low-pressure vacuum drain (n = 15)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (without vacuum drain) (n = 20)
Number of subjects: 35
Study: 32977777

Group type: EXPERIMENTAL
Intervention: Surgical conditions (treatment)
Number of subjects: 2909

Group type: EXPERIMENTAL
Intervention: Deaths outside health facility (surgical conditions)
Number of subjects: 2909

Group type: COMPARATOR
Intervention: Deaths from other medical conditions
Number of subjects: 2909

Group type: EXPERIMENTAL
Intervention: Surgical care received
Number of subjects: 2909

Group type: EXPERIMENTAL
Intervention: Health care sought
Number of subjects: 2909
Study: 34373362

Group type: EXPERIMENTAL
Intervention: Sodium alginate (orally administered for 3 days after EGD)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (no sodium alginate)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Treatment group (sodium alginate)
Number of subjects: 210
Study: 33050934

Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1061
Study: 35108114

Group type: EXPERIMENTAL
Intervention: Usual care plus peer-befriending (six visits between randomisation and four months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 56
Study: 33953741

Group type: COMPARATOR
Intervention: Bifrontal tDCS with anode over the left dorsolateral prefrontal cortex
Number of subjects: 25

Group type: COMPARATOR
Intervention: Frontoparietal tDCS
Number of subjects: 25